Benefits of stronger Neo‐Minophagen C in acute hepatitis after transarterial chemoembolization therapy for hepatomas
Open Access
- 14 October 2021
- journal article
- research article
- Published by Wiley in Advances in Digestive Medicine
- Vol. 10 (1), 8-14
- https://doi.org/10.1002/aid2.13305
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinomaClinical and Molecular Hepatology, 2017
- A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute ExacerbationClinical and Translational Gastroenterology, 2017
- Intravenous glycyrrhizin improved serum transaminases rapidly in a chronic hepatitis B patient with acute exacerbationJournal of the Formosan Medical Association, 2015
- Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature ReviewBioMed Research International, 2014
- Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapyAlimentary Pharmacology & Therapeutics, 2013
- Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In VitroPLOS ONE, 2013
- Glycyrrhizin as antiviral agent against Hepatitis C VirusJournal of Translational Medicine, 2011
- In vivo glycyrrhizin accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized ratsEuropean Journal of Pharmacology, 2008
- A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinomaCancer, 2002
- Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptorsEuropean Journal of Pharmacology, 2001